Topics

"Action Alert Regeneron Sanofi Celgene" Drugs and Medication Database

03:57 EDT 30th March 2020 | BioPortfolio

Here are the most relevant "Action Alert Regeneron Sanofi Celgene" Drugs and Medications that we have found in our database.

More Information about "Action Alert Regeneron Sanofi Celgene" on BioPortfolio

We have published hundreds of Action Alert Regeneron Sanofi Celgene news stories on BioPortfolio along with dozens of Action Alert Regeneron Sanofi Celgene Clinical Trials and PubMed Articles about Action Alert Regeneron Sanofi Celgene for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Action Alert Regeneron Sanofi Celgene Companies in our database. You can also find out about relevant Action Alert Regeneron Sanofi Celgene Drugs and Medications on this site too.

Showing "Action Alert Regeneron Sanofi Celgene" Drugs and Medications 1–25 of 34

Probably Relevant

Pomalyst [celgene corporation]

These highlights do not include all the information needed to use POMALYST safely and effectively. See full prescribing information for POMALYST. POMALYST (pomalidomide) capsules, for oral useInitial U.S. Approval: 2013

Possibly Relevant

Libtayo [regeneron pharmaceuticals, inc.]

These highlights do not include all the information needed to use LIBTAYO safely and effectively. See full prescribing information for LIBTAYO. LIBTAYO (cemiplimab-rwlc) injection, for intravenous useInitial U.S. Approval: 09/2018

Thalomid [celgene corporation]

These highlights do not include all the information needed to use THALOMID safely and effectively. See full prescribing information for THALOMID. THALOMID (thalidomide) capsules, for oral use Initial U.S. Approval: 1998

Avalide [sanofi-aventis u.s. llc]

These highlights do not include all the information needed to use AVALIDE safely and effectively. See full prescribing information for AVALIDE. AVALIDE (irbesartan and hydrochlorothiazide) tablets, for oral use Initial U.S. Approval: 1997

Methenamine hippurate [winthrop u.s.]

METHENAMINE HIPPURATE TABLETS, USP

Taxotere [sanofi-aventis u.s. llc]

These highlights do not include all the information needed to use TAXOTERE safely and effectively. See full prescribing information for TAXOTERE. TAXOTERE (docetaxel) injection, for intravenous use Initial U.S. Approval: 1996

Eylea [regeneron pharmaceuticals, inc.]

These highlights do not include all the information needed to use EYLEA safely and effectively. See full prescribing information for EYLEA. EYLEA (aflibercept) Injection, for Intravitreal InjectionInitial U.S. Approval: 2011

Elitek [sanofi-aventis u.s. llc]

These highlights do not include all the information needed to use ELITEK safely and effectively. See full prescribing information for ELITEK. ELITEK (rasburicase) for injection, for intravenous useInitial U.S. Approval: 2002

Xyzal [sanofi-aventis u.s. llc]

These highlights do not include all the information needed to use XYZAL safely and effectively. See full prescribing information for XYZAL. XYZAL (levocetirizine dihydrochloride) tablets, for oral useXYZAL (levocetirizine dihydrochloride) oral solutionIni

Revlimid [celgene corporation]

These highlights do not include all the information needed to use REVLIMID safely and effectively. See full prescribing information for REVLIMID. REVLIMID [lenalidomide] capsules, for oral use Initial U.S. Approval: 2005

Plavix [bristol-myers squibb/sanofi pharmaceuticals partnership]

These highlights do not include all the information needed to use PLAVIX safely and effectively. See full prescribing information for PLAVIX.   PLAVIX (clopidogrel bisulfate) tablets, for oral use Initial U.S. Approval: 1997

Oxygen [alert respiratory services, inc.]

Oxygen, Compressed

Arcalyst [regeneron pharmaceuticals, inc.]

These highlights do not include all the information needed to use ARCALYST safely and effectively. See full prescribing information for ARCALYST. ARCALYST (rilonacept)Injection for Subcutaneous UseInitial U.S. Approval: 2008

Triamcinolone acetonide [medvantx, inc.]

These highlights do not include all the information needed to use Triamcinolone Acetonide Nasal Spray safely and effectively. See full prescribing information for Triamcinolone Acetonide Nasal Spray. Triamcinolone Acetonide Nasal SprayFor intranasal use o

Triamcinolone acetonide [physicians total care, inc.]

These highlights do not include all the information needed to use Triamcinolone Acetonide Nasal Spray safely and effectively. See full prescribing information for Triamcinolone Acetonide Nasal Spray. Triamcinolone Acetonide Nasal SprayFor intranasal use o

Idhifa [celgene corporation]

These highlights do not include all the information needed to use IDHIFA safely and effectively. See full prescribing information for IDHIFA. IDHIFA (enasidenib) tablets, for oral use Initial U.S. Approval: 2017

Istodax [celgene corporation]

These highlights do not include all the information needed to use ISTODAX safely and effectively.  See full prescribing information for ISTODAX. ISTODAX (romidepsin) for injection, for intravenous use Initial U.S. Approval:  2009

Noritate [physicians total care, inc.]

NA

Vidaza [celgene corporation]

These highlights do not include all the information needed to use VIDAZA safely and effectively. See full prescribing information for VIDAZA. VIDAZA (azacitidine for injection), for subcutaneous or intravenous useInitial U.S. Approval: 2004

Praluent [sanofi-aventis u.s. llc]

These highlights do not include all the information needed to use PRALUENT safely and effectively. See full prescribing information for PRALUENT. PRALUENT (alirocumab) injection, for subcutaneous useInitial U.S. Approval: 2015

Ruby-fill [jubilant draximage inc.]

These highlights do not include all the information needed to use RUBY-FILL safely and effectively. See full prescribing information for RUBY-FILL.RUBY-FILL (rubidium Rb 82 generator)To produce rubidium Rb 82 chloride injection, for intravenous useInitial

Dupixent [sanofi-aventis u.s. llc]

These highlights do not include all the information needed to use DUPIXENT safely and effectively. See full prescribing information for DUPIXENT. DUPIXENT (dupilumab) injection, for subcutaneous useInitial U.S. Approval: 2017

Polyethylene glycol 3350 [emcure pharmaceuticals usa inc.]

Drug FactsActive ingredient (in each dose)Polyethylene Glycol 3350, 17 g (cap filled to line)PurposeOsmotic Laxative

Good sense acid reducer [bryant ranch prepack]

Perrigo Acid Reducer Drug Facts

Rifadin [sanofi-aventis u.s. llc]

RIFADIN (rifampin capsules USP) and RIFADIN IV (rifampin for injection USP)



Quick Search